Evofem Biosciences, Inc.
Pagina dedicata companiei Evofem Biosciences, Inc. listata cu simbolurile US.EVFM, US.EVFMc, US.EVFMcc
Descriere companie[edit | ]
Evofem Biosciences, Inc. (https://www.evofem.com/) is a commercial-stage biopharmaceutical company. The Company is engaged in developing and commercializing products to address needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from sexually transmitted infections (STIs). The Company's product, Phexxi vaginal gel, is an on-demand prescription contraceptive gel for women. Its pipeline product candidate, EVO100 vaginal gel, is evaluated for the prevention of chlamydia trachomatis infection and Neisseria gonorrhoeae in women. The Company also focuses on the development of EVO200 vaginal gel, its candidate for the reduction of recurrent bacterial vaginosis (BV).Its subsidiaries include Evofem Biosciences Operations Inc, Evofem Inc and Evofem Ltd.
Grafic actiuni companie[edit | ]